logo

RXRX

Recursion·NASDAQ
--
--(--)
--
--(--)
3.51 / 10
Netural

RXRX's fundamental score is 3.5/10, reflecting a structurally challenged profile. Key weaknesses include low current and fixed assets turnover ratios (0.0548 and 0.3097, respectively), a negative gross margin (-44.7973%), and only moderate revenue and profit relative to market value. Supportive factors such as Asset-MV and Profit-MV help mitigate the downside, yet the overall picture warrants guarded positioning until operational efficiency improves.

Fundamental(3.51)SentimentTechnical

Analysis Checks(5/10)

Revenue-MV
Value-3.88
Score2/3
Weight23.71%
1M Return11.69%
Inventory turnover ratio
Value47.85
Score3/3
Weight9.13%
1M Return5.26%
Gross profit margin (%)
Value-44.80
Score1/3
Weight-0.80%
1M Return-0.54%
Profit-MV
Value0.46
Score2/3
Weight15.56%
1M Return7.79%
PB-ROE
Value0.35
Score0/3
Weight7.10%
1M Return3.56%
Current assets turnover ratio
Value0.05
Score0/3
Weight-2.84%
1M Return-1.88%
Fixed assets turnover ratio
Value0.31
Score1/3
Weight-2.47%
1M Return-1.64%
Asset-MV
Value-0.50
Score2/3
Weight35.50%
1M Return15.13%
Cash-MV
Value-0.07
Score2/3
Weight15.58%
1M Return7.73%
Net profit / Total profit (%)
Value99.97
Score0/3
Weight-0.46%
1M Return-0.30%
Is RXRX undervalued or overvalued?
  • RXRX scores 3.51/10 on fundamentals and holds a Fair valuation at present. Backed by its -51.56% ROE, -1637.81% net margin, -2.66 P/E ratio, 1.65 P/B ratio, and -19.48% earnings growth, these metrics solidify its Netural investment rating.